Ionophore A23187-induced "C-serotonin secretion and thromboxane B.JTx&) formation were found to be absent in citrated platelet-rich plasma (PRP) from thrombasthenic subjects and in normal PRP treated with glycoprotein (GP) Ilb-llla complex-specific monoclonal antibodies. Both responses were restored to normal levels when 5 mmol/L EDTA was present, indicating that their absence was not caused by the absence of aggregation per se. In gel-filtered platelets (GFP) incubated with various additions, the blockade or absence of GPllb-llla resulted in reduced A23187-induced secretion and TxB2 formation in media containing 1 mmol/L Ca2+ with or without fibrinogen and 1 mmol/L Mg2+ plus fibrinogen, but not when Ca. Mg-free buffer alone, 1 mmol/L EDTA, or fibrinogen alone were present. In contrast, no such dependence or GPllb-llla was seen in GFP stimulated with thrombin or phorbol myristate acetate in the presence of 1 mmol/L Ca2+, 1 mmol/L EDTA, or buffer alone. The inhibition of ionophore-induced responses seen in both normal GFP treated with antibodies and thrombasthenic GFP was CTIVATION OF blood platelets by most, if not all, agonists is closely associated with increases in the cytoplasmic Caz+ concentration. Early evidence for this involvement of Ca" was obtained in part from studies demonstrating that ionophores, such as A23 187 and ionomycin, which transport divalent cations across membranes, could activate plate1ets.l4 The ability of the ionophores to induce secretion in the absence of aggregation in systems containing EDTA to remove extracellular divalent cation^'.^.^*^ indicated that platelets could use an intracellular source of calcium for activation and that secretion could be induced under these conditions independently of aggregation.
Ionophore A23187-induced "C-serotonin secretion and thromboxane B.JTx&) formation were found to be absent in citrated platelet-rich plasma (PRP) from thrombasthenic subjects and in normal PRP treated with glycoprotein (GP) Ilb-llla complex-specific monoclonal antibodies. Both responses were restored to normal levels when 5 mmol/L EDTA was present, indicating that their absence was not caused by the absence of aggregation per se. In gel-filtered platelets (GFP) incubated with various additions, the blockade or absence of GPllb-llla resulted in reduced A23187-induced secretion and TxB2 formation in media containing 1 mmol/L Ca2+ with or without fibrinogen and 1 mmol/L Mg2+ plus fibrinogen, but not when Ca. Mg-free buffer alone, 1 mmol/L EDTA, or fibrinogen alone were present. In contrast, no such dependence or GPllb-llla was seen in GFP stimulated with thrombin or phorbol myristate acetate in the presence of 1 mmol/L Ca2+, 1 mmol/L EDTA, or buffer alone. The inhibition of ionophore-induced responses seen in both normal GFP treated with antibodies and thrombasthenic GFP was CTIVATION OF blood platelets by most, if not all, agonists is closely associated with increases in the cytoplasmic Caz+ concentration. Early evidence for this involvement of Ca" was obtained in part from studies demonstrating that ionophores, such as A23 187 and ionomycin, which transport divalent cations across membranes, could activate plate1ets.l4 The ability of the ionophores to induce secretion in the absence of aggregation in systems containing EDTA to remove extracellular divalent cation^'.^.^*^ indicated that platelets could use an intracellular source of calcium for activation and that secretion could be induced under these conditions independently of aggregation.
Although it has been suggested that the increase in cytoplasmic calcium ([Ca2'Ii) itself may be sufficient to induce aggregation and/or secretion: other studies indicate that elevation of [Caz+Ii triggers subsequent events that are required for the occurrence of these responses. Thus, secretion induced by A23 187 has been reported to have an absolute requirement for intact thromboxane (Tx) formation and a strong dependency on aggregati~n.~ Further evidence for such a Tx dependency is also provided by our observations that patients with platelet abnormalities characteristic of cyclo-oxygenase deficiency have markedly impaired responses to A23187,8 and by the observations of Shattil and Brass' that fibrinogen receptor expression induced by elevating [Ca2+Ji directly in saponin-permeabilized platelets is abolished in the presence of a cyclo-oxygenase inhibitor. Rittenhouse'os'' has also shown that secretion induced by low concentrations of ionophores is strongly inhibited by aspirin plus adenosine diphosphate (ADP) scavengers, and that the secondary stimuli that these inhibitors block (cyclooxygenase metabolites and ADP) are solely responsible for phospholipase C activation.
The studies we report here have examined the involvement of the platelet integrin cyI& (glycoprotein [GP] IIb-IIIa) in ionophore-induced platelet activation, and are derived from initial observations of marked differences in the ability of not associated with any significant alteration of the ionophore-mediated [Ca2+], increase, as measured in both aequorin-loaded GFP stimulated with A23187 and fura-2-loaded GFP stimulated with ionomycin. Incubation of normal GFP with either the monoclonal antibodies or the ligand binding site peptide RGDS in the presence of 1 mmol/L Ca2+ caused virtually complete inhibition of A23187-induced aggregation, measured as the loss of single platelets, but RGDS, in contrast to the antibodies, did not inhibit secretion or TxBz formation. We conclude that platelet activation induced by ionophores in the presence, but not in the absence, of extracellular divalent cations involves a GPllb-Ma-dependent process that most likely involves a property of the ligand-occupied form of the complex distinct from its ability to support aggregation. This could represent another example of an aggregation-independent activity of the receptoroccupied state of the GPllb-llla complex in signal transduction. 0 1994 b y The American Society of Hematology.
A23187 to induce secretion and Tx formation in plateletrich plasma (PW) from normal versus thrombasthenic subjects. The GPIIb-IIIa complex is an essential mediator of platelet aggregation via its ability to bind fibrin~gen,".'~ as shown by the absence of aggregation and fibrinogen binding in GPIIb-IIIa-deficient platelets from subjects with Glanzmann's
In addition, IIb-IIIa has also been implicated in other aspects of platelet activation, including Ca" homeostasis'6"s and stimulated Ca2+ flu~es,'~-'' cyclic adenosine monophosphate (AMP) regulation," Na'-H+ e~change,'~ cytoskeletal reorgani~ation,2~~" the accumulation of 3-phosphorylated phosphoino~itides,~~ and the activation of phospholipase C?' calpain,26 and tyrosine kinase^^^.^^ and phosphata~es.'~ Whether, and which of, these effects of GPIIb-IIIa are secondary to its ability to promote aggregation or result directly from ligand interactions with the complex is not entirely clear.30 The activation of certain tyrosine kinases has been attributed specifically to the binding of multimeric ligands, such as fibrinogen, to IIb-IIIa, and has been shown to precede platelet aggregation." Ligand binding is known to induce conformational alterations in the IIb-IIIa previously." Normal subjects were hospital and laboratory personnel who denied ingestion o f drugs during the 7-to 10-day period before study. 
Statistics

RESULTS
A23187-induced responses in citrated PRP.
This study is derived from initial observations of marked differences in A23187-induced activation of citrated PRP from normal subjects and from patients with Glanzmann's thrombasthenia, whose platelets are deficient in GPIIb-IIIa. Stimulation of citrated thrombasthenic PRP with 15 pmol/L A23 187 resulted not only in the expected absence of aggregation, but also in an absence of secretion and TxB2 formation, despite the known ability of A23 187 to induce these responses independently of aggregati~n'.'.~" (Fig 1A) . However, the inability of thrombasthenic platelets to aggregate did not appear to be responsible for the absence of secretion and TxB2 formation, because A23187 induced similar extents of secretion, and similar or even increased TxB2 formation (measured in l patient) in thrombasthenic and normal PRP when 5 mmol/L EDTA was present (Fig 1B) .
The ability of EDTA to restore secretion to normal levels 2551 in thrombasthenic PRP was not seen with other agonists. Secretion induced by collagen and arachidonate was also decreased in thrombasthenic PRP, compared with that in normal PRP, but was reduced even further in both cases by the addition of EDTA (Table 1) .
To determine whether the absence of A23187-induced responses in thrombasthenic PRP could be attributed specifically to the absence of GPIIb-IIIa, we tested the effects of the complex-specific MoAb W-CP8 on A23187-induced responses in normal PRP. Incubation with Fab' fragments of CP8 for 2 minutes before the addition of A23 187 produced responses identical to those in thrombasthenic PRP: secretion and TxB2 formation were abolished in citrated PRP, but unaffected in PRP containing 5 mmoVL EDTA (Fig 2) . Incubation with Fab' fragments of LJ-P10, which is also specific for an epitope on GPIIb-IIIa but inhibits neither fibrinogen binding nor aggregati~n,~~ had no effect on these responses (Fig 2) .
A23187-induced responses in GFP.
To determine what factors might be responsible for the inhibition of A23187-induced responses seen in PRP in the absence but not in the presence of EDTA, the effects of the absence or blockade of IIb-IIIa were tested in GFP containing various additions, including 1 mmol/L Ca" with or without fibrinogen, 1 mmoVL Mg2+ or 1 mmoVL EDTA with fibrinogen, and fibrinogen or Ca, Mg-free buffer alone (Fig 3) . In these studies, identical inhibitory patterns were obtained with W-CP8 IgG and Fab' fragments, and with MoAb M148 (IgG) and LJ-CP8. The results shown in Fig 3 are therefore combined data from experiments using LJ-CP8 or M148 IgG.
A23 187-induced secretion was markedly reduced in thrombasthenic GFT and in normal GFT treated with antibody in all cases in which Ca2+ or Mg2+ was present. In contrast, when 1 mmoVL EDTA was present, secretion was unaltered by treatment with antibody, and occurred to a similar extent in thrombasthenic GFT. Secretion was also not altered significantly when Ca, Mg-free buffer alone was added (Fig 3, buffer) , indicating that the absence of effect with EDTA was not caused by the EDTA itself.
When fibrinogen alone was added without divalent cations, the extent of secretion in normal GFP treated with antibody varied markedly. Although secretion was reduced on average in the 6 subjects tested (Fig 3, fib) , this response was unaffected or only slightly reduced in 3 subjects, but was 442 ? 110 (n = 3) nmoles per 10" platelets with buffer virtually abolished in the 3 others. In contrast, the extent of added, 574 ? 74 (n = 4) with EDTA and fibrinogen added, secretion in each of the 3 thrombasthenic subjects was simiand 387 ? 43 (n = 5 ) with Ca" and fibrinogen added lar to that obtained in the presence of EDTA or buffer.
(differences not significant). The amounts of TxB, formed TxB2 formation was more variable than secretion, but disin the presence of antibody were 92% ? 16% (buffer), 97% played a generally similar pattern. TxBz in normal controls ? 2% (EDTA plus fibrinogen), and 6% -C 2% (Ca2' plus For personal use only. on October 30, 2017. by guest www.bloodjournal.org From GFP was stimulated by 2 pmoVL A23187 in the presence of the same additions as those described in Fig 3. Lysis was measured after 5 minutes of stimulation. Values shown are means ? SEM for n = 5. FITC-LJCP8 binding was measured after 2 minutes of incubation at 37°C by flow cytometry as described in Materials and Methods. Percent positive is the percentage of total particles with fluorescence intensities above the upper edge of the autofluorescence peak (no antibody added), and the mean fluorescence intensities are the values obtained on 5,000 cells; autofluorescence was 1.7. The values given for both parameters are the means of duplicate measurements.
fibrinogen) of the amounts formed in the absence of antibody. Similarly, TxB, formation in the 3 thrombasthenics was 461 2 125 nmoles per 10" platelets with buffer alone and 759 2 37 with EDTA plus fibrinogen added, but only 55 ? 37 with Ca2' and fibrinogen added.
Preliminary studies suggest that the inhibition of responses seen in the presence of Mg2+ may be caused, at least in part, by the presence of residual calcium. In some subjects, secretion and TxB2 formation in GFP containing l mmom Mg2+ were inhibited by antibody to a lesser extent (37% f-9% inhibition) when 0.1 mmol/L EGTA was present than when it was absent (87% ? 4% inhibition), thus suggesting a specific role for ca".
The differential effects of the antibodies in the presence or absence of extracellular divalent cations were not caused by differences in the extents of cell lysis or in the extents of antibody binding to platelets under these conditions. Table  2 indicates that comparable extents of lysis (<5%) were obtained under all conditions studied in both the presence and absence of W-CP8. Table 2 also presents the relative extents of FITC-labeled W-CP8 binding to GFP, determined for the same incubation conditions as in Fig 3. The percentage of platelets positive for FITC-LJ-CP8 binding was identical under all conditions, indicating that the antibody bound to GPIIb-IIIa in all cases. The mean fluorescence intensities, which reflect the relative number of antibody molecules bound per platelet, were also similar for all conditions except for the one-third lower value obtained in the presence of EDTA. Thus, the number of antibody molecules interacting with IIb-IIIa was reduced specifically by EDTA, which has been shown previously to cause dissociation of the IIb-IIIa complex at 37°C,45-47 but was not altered by the absence vs presence of added divalent cations.
Spec$city of the Ilb-llla dependency for ionophore-induced responses. The dependence of secretion and TxB, formation on IIb-IIIa in GFP, as in PRP, was specific for stimulation by ionophore. As shown in Table 3 , the extents of secretion induced by 0.1 U/mL thrombin and 0.2 pmoV L PMA were similar in thrombasthenic GFP and in normal GFP in the presence or absence of LJ-CP8 on addition of buffer, 1 mmol/L CaZ+, or 1 mmoVL EDTA. Thrombininduced TxB2 formation was also not altered significantly by the presence of LJ-CP8 or in thrombasthenic GFP. PMA did not induce significant amounts of TxB, formation in normal or thrombasthenic GFP.
A231 87 dose-dependency of Ilb-llla-mediated responses. Whether increasing concentrations of A23187 could overcome the IIb-IIIa dependency of platelet responses was examined in normal GFP in the presence of 1 mmoVL Ca2+. In response to 0.5, 1, and 2 pmol/L A23187, secretion in the presence of LJ-CP8 was reduced to 29%, 24%, and 28% (mean of 2 experiments), respectively, of that in the absence of antibody, whereas with 5 and 7.5 pmoVL A23187, secretion in the presence of antibody was 95% and 100% of that in its absence. However, cell lysis was less than 5% at 2 pmol/L or less of A23 187, but increased to 15% and 21 % at the two higher concentrations. Thus, within the limits of nonlytic concentrations of A23187, the IIb-IIIa dependency was not overcome by increasing ionophore concentrations.
Zonophore-induced increase in cytoplasmic Ca2+ levels. To determine whether this 1%-IIIa dependence could be related to effects on the ionophore-mediated [Ca2+Ii increase, secretion, TxB, formation, and [Ca2+Ii levels were measured in platelets loaded with aequorin. The shapes of the aequorin peaks and the estimated relative increases in [Ca2+Ii produced by 2 pmol/L A23 187 in the presence of l mmom Ca2+ were similar in normal platelets, normal platelets treated with LJ-CP8, and thrombasthenic platelets, despite the marked reductions in secretion and TxB, formation in the latter two cases (Fig 4) . In addition, in fura-2-loaded normal platelets in the presence of 1 mmol/L Ca2+, the extent of ionomycin-induced secretion was also reduced by LJ-CP8 and M148 with no alteration in the [Ca"], increase (Fig 5) .
Efsects of RGDS on A23187-induced responses. We also compared the effects on A23187-induced responses of the ligand binding site peptide RGDS, which also blocks platelet aggregation?' with those of the MoAbs. In distinct contrast to the antibodies, RGDS had no effect on the extent of secretion induced by A23187 in the presence of 1 mmol/L Ca2+, and even increased TxB2 formation ( P < .05, Table 4 ).
However, RGDS was equally effective as LJ-CP8 and M148 in blocking aggregation, as measured by the loss of single platelets (Fig 6) .
In some studies in which RGDS obtained from commercial sources was used, we did observe inhibition of secretion and Tx formation as well as of aggregation, similar to the For personal use only. on October 30, 2017. by guest www.bloodjournal.org From GFP was incubated with 58 pg/mL LJ-CP8 for 2 minutes at 37°C before the addition of agonist, and samples for secretion and TxB2 taken 5 minutes after agonist addition. TxB2 formation by PMA was not significant under any of the conditions tested.
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effects of the MoAbs. However, when these RGDS preparaionophore-induced activation, because it was not observed tions were chromatographed on Sephadex G-IO, their ability with thrombin or PMA, and appears to involve a property to inhibit secretion was greatly reduced or eliminated comof the GPIIb-IIIa complex distinct from its ability to support pletely, whereas their inhibitory activity towards aggregation aggregation. was unaffected. Thus, it appears that some commercial
The absence of A23187-stimulated secretion and Tx for-RGDS preparations may contain substances, probably of mation in citrated PRP from thrombasthenics seen in these higher molecular weight, that can alter their interactions with studies differs from a previous report of normal responses GPIIb-IIIa.
in thrombasthenic PRP.6 We believe this discrepancy may
DISCUSSION
Using both GPIIb-IIIa-deficient platelets from thrombasthenic subjects and normal piatelets in which GPHb-IIIa was blocked by complex-specific inhibitory MoAbs, we have shown that the induction of secretion and Tx formation by divalent cation ionophores exhibits a dependence on GPIIbIIIa in the presence, but not in the absence, of extracellular divalent cations. This dependence appears to be specific for 
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be caused by a difference in techniques used to stop the platelet responses. In the previous studies, EDTA alone instead of EDTA plus formaldehyde was used to stop activation, but it has been shown that, especially with ionophore, formaldehyde is necessary to prevent close cell contact-induced activation from occurring during centrifugation:' Although the dependence of the ionophore-induced responses on GPIIb-IIIa was observed only under conditions that favor aggregation, ie, in the presence of divalent cations, For personal use only. on October 30, 2017. by guest www.bloodjournal.org From have shown that aggregation per se is not required for induction of secretion by ionophores, and our observations here that secretion and Tx formation were inhibited by the MoAbs, but not by RGDS, despite complete inhibition of aggregation by both substances, indicates that the inhibition of these responses did not result from the absence of aggregation. Thus, GPIIb-IIIa appears to mediate these responses via a property distinct from its ability to support aggregation.
This mediation may therefore represent another example of an activity of GPIIb-IIIa that is specific to the receptoroccupied form of the complex. Ligand binding to GPIIb-IIIa has been shown to expose new, antigenic sites on the complex that may be involved in subsequent activation events, including signal transd~ction.~'.~' Several such ligand-induced binding sites (LIBS) have been identified,3' and antibodies raised against epitopes associated with these sites inhibit platelet adhesion to collagen5" and fibrin clot retrac- GFP containing 1 mmol/L Caz+ was incubated at 37°C for 2 minutes with RGDS or W-CP8 before the addition of 2 mmol/L A23187. Samples for "C-5HT and TxBz formation were obtained 5 minutes after A23187 addition. Values shown are means -t SEM for n = 6. P < .05 versus buffer.
J ""- which is consistent with our finding that RGDS did not cause inhibition of ionophore-induced secretion, and even significantly increased TxB2 formation. A number of signal transduction events have been related to ligand binding to GPIIb-IIIa, and thus could be involved in the IIb-IIIa dependence seen here. These include stimulated Ca" fl~xes,'~-'' cyclic AMP regulation," Na+-H+ exchange:3 cytoskeletal reorganization:'." the accumulation of 3-phosphorylated phosphatidylinositols,'5 and the activation of phospholipid C," calpain,26 and tyrosine kinases"*'* and phosphatase^.^^ However, at least some of these events appear to be dependent on the induction of aggregation rather than on ligand binding to IIb-IIIa specifically:" and most of them are inhibited by RGDS. Whereas activation of certain tyrosine kinases has been related specifically to ligand binding, this activation was observed only with multimeric ligands, and was also inhibited by RGDS.28 The GPIIb-IIIa dependency of the ionophore-induced responses thus differs from the IIb-IIIa dependence of most of these events, and could therefore reflect a new, as yet undefined, role of the ligand-occupied form of GPIIb-IIIa in mediating a process of signal transduction. Results obtained in our, and previous, studies suggest several mechanisms that may account for the IIb-IIIa dependency of ionophore-induced activation in the presence of divalent cations.
We observed that blocking GPIIb-IIIa inhibited not only secretion, but Tx formation as well. Because ionophore-induced secretion may be Tx dependent>8 this finding raises the possibility that 1%-IIIa is required for the induction of secretion through its capacity to mediate Tx synthesis. We attempted to determine whether a IIb-IIIa requirement for secretion could be observed independently of Tx synthesis
For using aspirin-or indomethacin-treated platelets, but were unsuccessful because inhibition of cyclo-oxygenase reduced secretion to levels too low to observe any significant inhibition by the antibodies. However, other studies using A23 187l0 and ionomycin" in concentrations comparable with those in the present study have found secretion to be less sensitive to inhibition of Tx synthesis than observed in our studies, and in one study,6 no Tx dependence at all was found. Although the extent to which ionophore-induced secretion is dependent on Tx formation may therefore not yet be completely defined, it is clearly greater than that for the response induced by thrombin or PMA, for which no IIb-IIIa dependence was found. Secretion induced by 0. I U/ mL thrombin is completely unaffected by cyclo-oxygenase inhibition," and PMA-induced secretion occurs in the absence of significant amounts of TxB2 formation ( Table 2 ).
In addition, there are other activation mechanisms that are Tx-dependent when induced by ionophores, but are Txindependent when induced by thrombin or PMA. One such mechanism is the activation of phospholipase C, with resulting formation of IP3 and diglyceride, the latter enhancing the activation of protein kinase C. These activation steps require thromboxane formation when induced by ionophores."." In contrast, phospholipase C is activated by thrombin directly via a receptor-linked G-protein-dependent pathway5' and PMA activates protein kinase C directly.53 Our observations that secretion induced by both thrombin and PMA is independent of IIb-IIIa is thus consistent with the hypothesis stated above that the specificity of the IIbIIIa requirement for activation by ionophores may be linked to the Tx dependency of this process.
The specificity of the GPIIb-IIIa dependence for activation in the presence of extracellular divalent cations suggests that there may be distinct mechanisms for ionophore-induced activation, depending on whether extracellular divalent cations, most likely Ca2+, are present or absent. The effect of the absence of these cations cannot be to alter the properties of GPIIb-IIIa to prevent inhibition by the antibodies, because the normal responses seen in thrombasthenic platelets indicates that GPIIb-IIIa is not required at all in the absence of divalent cations. The ionophores may therefore stimulate secretion and Tx formation by two distinct, and possibly mutually exclusive, mechanisms: a GPIIb-IIIa-dependent pathway that operates when extracellular Ca2+ is present, and a IIb-IIIa-independent pathway that operates in its absence.
Differences in the platelet responses to ionophore in the presence and absence of extracellular divalent cations suggesting different mechanisms of activation have also been found previously. The studies of Holmsen and Dangelmaier,' as well as our showed that secretion induced by A23 187 was progressively reduced and delayed with increasing concentrations of extracellular divalent cations, including Ca", compared with the response in the presence of EDTA or EGTA, and both studies suggested that these differences For personal use only. on October 30, 2017. by guest www.bloodjournal.org From could be caused by the interaction of platelets with ionophore-divalent cation complexes versus free ionophore. In addition, White% found that calpain was activated by A23 187 in the presence, but not in the absence, of extracellular calcium, and noted that several platelet proteins were hydrolyzed during ionophore stimulation in the presence of calcium, which were not hydrolyzed when calcium was absent, or during stimulation with other agonists.
One event that occurs in the presence of extracellular cations and has been linked to GPIIb-IIIa is calcium influx. It is entirely possible that influx via membrane Ca" channels may occur in ionophore-stimulated platelets in addition to ionophore-mediated transport, and could even be the major pathway for external Ca" entry if the conclusion of the studies cited that the platelet plasma membrane may be impermeable to ionophore-Ca2+ complexes, is correct. An involvement of GPIIb-IIIa in Ca" influx stimulated by other agonists has been reported in some st~dies,'~-~' but refuted in another.55 GPIIb-IIIa incorporated into liposomes has been shown to support Ca" influx into the liposomes,'* and, of particular relevance to our results, this activity was inhibited by antibody M148 but not by RGDS.56
The effects of the antibodies and RGDS on the ionophoreinduced responses that we observed are thus consistent with the putative role of GPIIb-IIIa in mediating Ca" influx. However, we also found that the overall increase in [Ca2+li induced by the ionophores, as measured by both aequorin and fura-2, was not altered by the absence or blockade of IIb-IIIa, whereas a reduction in [Ca"], might be anticipated if inhibition of the ionophore-induced responses were caused by elimination of a IIb-IIIa-mediated Ca2+ influx. However, as discussed previously by Fox et a1?6 it is possible that IIbIIIa could mediate a very localized influx of CaZ+, changes in which might not alter the relatively large overall increase 2557 in [Ca*+], that is reported by aequorin and fura-2. If such an influx were directly linked to subsequent activation events, then this could account for the specificity of the IIb-IIIa effects for the presence of extracellular cations. Furthermore, if the activation events linked to a IIb-IIIa-mediated Ca" influx were those leading to Tx formation, eg, activation of phospholipase A2, then, as discussed above, this could also account for the specificity of the IIb-IIIa effects for activation by ionophores.
These concepts of the pathways associated with the induction of secretion and TxB2 by ionophores in both the presence and absence of extracellular divalent cations, and our hypotheses of the sites at which GPIIb-IIIa could be involved, are presented schematically in Fig 7. When platelets interact with free ionophore in the absence of extracellular Ca", Tx formation, phospholipase C activation, and secretion are initiated solely by the release of internal Ca" stores and none of these events are influenced by GPIIb-IIIa. When extracellular Ca" is present, we presume that the ionophores elevate [CaZ+li by a combination of direct transport of external Ca2+, Ca2+ influx via membrane channels, and possibly internal Ca" release as well. It is not clear whether the internal Ca2+ release induced by ionophores in the absence of extracellular cations occurs to the same extent, or at all, in the presence of external Ca2+ entry, because present methods for monitoring [Ca2'li levels in platelets can not directly distinguish between Ca" derived from these two sources. GPIIb-IIIa mediation of Tx formation and secretion, via a property of the ligand-occupied form of the integrin, is seen only when Ca" movement across the membrane occurs. The putative sites for GPIIb-IIIa involvement include Ca" influx, possibly via a channel that is specifically associated with IIb-IIIa, the events leading to Tx formation, or Tx-dependent phospholipase C activation. Further studies to explore these PLATELETS + IONOPHORE 
